Freeman Roy Lester has filed 18 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 22640 shares of Inhibikase Therapeutics, Inc. ($IKT) on February 14, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 14, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Freeman Roy Lester | Not found | A | Stock Option (Right to Buy) | 22640 | $0.00 | 22,640.0000 | 23,712,220 | 9999.99% | 0.10% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Freeman Roy Lester | Not found | D | Stock Option (Right to Buy) | 21854 | $0.00 | 0.0000 | 23,712,220 | 100.00% | 0.09% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Freeman Roy Lester | Not found | A | Stock Option (Right to Buy) | 21854 | $0.00 | 21,854.0000 | 23,712,220 | 9999.99% | 0.09% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Freeman Roy Lester | Not found | D | Stock Option (Right to Buy) | 1138 | $0.00 | 0.0000 | 23,712,220 | 100.00% | 0.00% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Freeman Roy Lester | Not found | A | Stock Option (Right to Buy) | 1138 | $0.00 | 1,138.0000 | 23,712,220 | 9999.99% | 0.00% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Freeman Roy Lester | Not found | D | Stock Option (Right to Buy) | 3780 | $0.00 | 0.0000 | 23,712,220 | 100.00% | 0.02% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Freeman Roy Lester | Not found | A | Stock Option (Right to Buy) | 3780 | $0.00 | 3,780.0000 | 23,712,220 | 9999.99% | 0.02% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Freeman Roy Lester | Not found | D | Stock Option (Right to Buy) | 6667 | $0.00 | 0.0000 | 23,712,220 | 100.00% | 0.03% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Freeman Roy Lester | Not found | A | Stock Option (Right to Buy) | 6667 | $0.00 | 6,667.0000 | 23,712,220 | 9999.99% | 0.03% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Freeman Roy Lester | Not found | D | Stock Option (Right to Buy) | 6667 | $0.00 | 0.0000 | 23,712,220 | 100.00% | 0.03% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Freeman Roy Lester | Not found | A | Stock Option (Right to Buy) | 6667 | $0.00 | 6,667.0000 | 23,712,220 | 9999.99% | 0.03% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Freeman Roy Lester | Not found | D | Stock Option (Right to Buy) | 30000 | $0.00 | 0.0000 | 23,712,220 | 100.00% | 0.13% |
| Jan. 21, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Freeman Roy Lester | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 23,712,220 | 9999.99% | 0.13% |
| Jan. 3, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Freeman Roy Lester | Not found | A | Stock Option (Right to Buy) | 344452 | $0.00 | 344,452.0000 | 23,712,220 | 9999.99% | 1.45% |
| Jan. 3, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Freeman Roy Lester | Not found | A | Stock Option (Right to Buy) | 172191 | $0.00 | 172,191.0000 | 23,712,220 | 9999.99% | 0.73% |
| Jan. 3, 2025 | Inhibikase Therapeutics, Inc. | $IKT | Freeman Roy Lester | Not found | A | Stock Option (Right to Buy) | 316647 | $0.00 | 316,647.0000 | 23,712,220 | 9999.99% | 1.34% |
| July 16, 2024 | Inhibikase Therapeutics, Inc. | $IKT | Freeman Roy Lester | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 6,028,210 | 9999.99% | 0.50% |
| June 30, 2023 | Inhibikase Therapeutics, Inc. | $IKT | Freeman Roy Lester | Not found | A | Stock Option (right to buy) | 6667 | $0.00 | 6,667.0000 | 0 | 9999.99% | 0.00% |